Ghent University Academic Bibliography

Advanced

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use

Johanna MW Hazes, Pierre G Coulie, Vincent Geenen, Severine Vermeire, Franck Carbonnel, Edouard Louis, Pierre Masson and Filip De Keyser UGent (2011) RHEUMATOLOGY. 50(11). p.1955-1968
abstract
It has long been known that pregnancy and childbirth have a profound effect on the disease activity of rheumatic diseases. For clinicians, the management of patients with RA wishing to become pregnant involves the challenge of keeping disease activity under control and adequately adapting drug therapy during pregnancy and post-partum. This article aims to summarize the current evidence on the evolution of RA disease activity during and after pregnancy and the use of anti-rheumatic drugs around this period. Of recent interest is the potential use of anti-TNF compounds in the preconception period and during pregnancy. Accumulating experience with anti-TNF therapy in other immune-mediated inflammatory diseases, such as Crohn's disease, provides useful insights for the use of TNF blockade in pregnant women with RA, or RA patients wishing to become pregnant.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
Disease activity, Pregnancy, Rheumatoid arthritis, Pregnancy outcome, Drug treatment, Anti-TNF, Review, INFLAMMATORY-BOWEL-DISEASE, OF-THE-LITERATURE, NECROSIS-FACTOR ANTAGONISTS, REGULATORY T-CELLS, IMMUNOGLOBULIN-G, CROHNS-DISEASE, TNF-ALPHA, AZATHIOPRINE TREATMENT, MONOCLONAL-ANTIBODY, ANTIRHEUMATIC DRUGS
journal title
RHEUMATOLOGY
Rheumatology
volume
50
issue
11
pages
1955 - 1968
Web of Science type
Review
Web of Science id
000296295800006
JCR category
RHEUMATOLOGY
JCR impact factor
4.058 (2011)
JCR rank
9/29 (2011)
JCR quartile
2 (2011)
ISSN
1462-0324
DOI
10.1093/rheumatology/ker302
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1975402
handle
http://hdl.handle.net/1854/LU-1975402
date created
2011-12-29 10:54:22
date last changed
2012-01-04 08:59:25
@article{1975402,
  abstract     = {It has long been known that pregnancy and childbirth have a profound effect on the disease activity of rheumatic diseases. For clinicians, the management of patients with RA wishing to become pregnant involves the challenge of keeping disease activity under control and adequately adapting drug therapy during pregnancy and post-partum. This article aims to summarize the current evidence on the evolution of RA disease activity during and after pregnancy and the use of anti-rheumatic drugs around this period. Of recent interest is the potential use of anti-TNF compounds in the preconception period and during pregnancy. Accumulating experience with anti-TNF therapy in other immune-mediated inflammatory diseases, such as Crohn's disease, provides useful insights for the use of TNF blockade in pregnant women with RA, or RA patients wishing to become pregnant.},
  author       = {Hazes, Johanna MW and Coulie, Pierre G and Geenen, Vincent and Vermeire, Severine and Carbonnel, Franck and Louis, Edouard and Masson, Pierre and De Keyser, Filip},
  issn         = {1462-0324},
  journal      = {RHEUMATOLOGY},
  keyword      = {Disease activity,Pregnancy,Rheumatoid arthritis,Pregnancy outcome,Drug treatment,Anti-TNF,Review,INFLAMMATORY-BOWEL-DISEASE,OF-THE-LITERATURE,NECROSIS-FACTOR ANTAGONISTS,REGULATORY T-CELLS,IMMUNOGLOBULIN-G,CROHNS-DISEASE,TNF-ALPHA,AZATHIOPRINE TREATMENT,MONOCLONAL-ANTIBODY,ANTIRHEUMATIC DRUGS},
  language     = {eng},
  number       = {11},
  pages        = {1955--1968},
  title        = {Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use},
  url          = {http://dx.doi.org/10.1093/rheumatology/ker302},
  volume       = {50},
  year         = {2011},
}

Chicago
Hazes, Johanna MW, Pierre G Coulie, Vincent Geenen, Severine Vermeire, Franck Carbonnel, Edouard Louis, Pierre Masson, and Filip De Keyser. 2011. “Rheumatoid Arthritis and Pregnancy: Evolution of Disease Activity and Pathophysiological Considerations for Drug Use.” Rheumatology 50 (11): 1955–1968.
APA
Hazes, J. M., Coulie, P. G., Geenen, V., Vermeire, S., Carbonnel, F., Louis, E., Masson, P., et al. (2011). Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. RHEUMATOLOGY, 50(11), 1955–1968.
Vancouver
1.
Hazes JM, Coulie PG, Geenen V, Vermeire S, Carbonnel F, Louis E, et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. RHEUMATOLOGY. 2011;50(11):1955–68.
MLA
Hazes, Johanna MW, Pierre G Coulie, Vincent Geenen, et al. “Rheumatoid Arthritis and Pregnancy: Evolution of Disease Activity and Pathophysiological Considerations for Drug Use.” RHEUMATOLOGY 50.11 (2011): 1955–1968. Print.